The case that Ozempic (NVO) and other GLP-1 medications could help people with substance use disorders is getting stronger.

New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health ...

New popular weight-loss and anti-diabetes drugs may reduce the rate of opioid overdose or alcohol intoxication in people with ...

Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid ...

Weight loss drug Ozempic and type 2 diabetes jabs could be used to tackle binge drinking - Doctors and NHS England’s chief ...

Researchers from Loyola University Chicago are adding to the growing evidence suggesting that medications like Ozempic can ...

Ozempic, a popular drug for treating diabetes and promoting weight loss, has emerged as an unexpected weapon in the fight ...

The weight-loss drugs are linked with reduced rates of excess drinking and opioid overdoses, suggesting they may tamp down ...

The British government announced a multimillion dollar pharmaceutical partnership with Eli Lilly, including a trial that will ...

Poor purity can cause patients to experience fever, chills, nausea, skin irritation, infections and low blood pressure.

The number of U.S. children who suffer seizures after swallowing prescription medications or illicit drugs has doubled in ...

GLP-1 receptor agonists and similar drugs may protect people with opioid or alcohol use disorder from opioid overdose and ...